
Our screening laboratory is based outside Boston in Billerica, Massachusetts. This site features a variety of mass spectrometers, ensuring that the ideal instrument can be used for each specific application, as well as integrated platforms for automated sample processing and compound/library management. These capabilities are essential to ensure that large-scale, high-throughput screens can be performed rapidly, reproducibly, and methodically. Beyond our instrumentation and organization, our screening services are supported by an expert scientific team. Our core team of scientists and engineers have been serving clients with mass spectrometry-based services for over twenty years, giving them deep experience with a diverse array of applications and the ability to successfully solve challenging problems for our clients.
As a CRO specializing in mass spectrometry for high-throughput screening and proteomics, these screening capabilities drive our ability to support research teams through the drug discovery process. We specialize in label-free high-throughput screening approaches, including ASMS (Affinity Selection Mass Spectrometry) for non-covalent screening, Intact MS for covalent screening, and RapidFire-MS for functional screening. By partnering with a knowledgeable CRO like Momentum Biotechnologies, you gain access to significant expertise in screening, follow-up, and data analysis, helping to ensure that you get accurate, physiologically relevant hits.
In addition to performing high-throughput screens, we can offer support for compound management across in-house libraries, client libraries, and third-party libraries. We leverage cutting-edge technology in combination with purpose-built computational workflows to enable effective screening of chemical libraries of virtually any size and type.

